References
- 1. DeSantis CE, Bray F, Ferlay J, Lortet-Tieulent J, Anderson BO, Jemal A. International Variation in Female Breast Cancer Incidence and Mortality Rates. Cancer Epidemiol Biomarkers Prev. 2015;24(10):1495-1506.10.1158/1055-9965.EPI-15-0535
- 2. Coates AS, Winer EP, Goldhirsch A. Tailoring therapies - improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol. 2015;26(8):1533-1546.10.1093/annonc/mdv221
- 3. Ferrari A, Rovera F, Dionigi P, et al. Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer. Expert Rev Anticancer Ther. 2006;6(10):1503-1515.10.1586/14737140.6.10.1503
- 4. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis A Randomized Clinical Trial. JAMA. 2011;305(6):569-575.10.1001/jama.2011.90
- 5. Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303-1310.10.1016/S1470-2045(14)70460-7
- 6. Mocellin S, Goldin E, Marchet A, Nitti D. Sentinel node biopsy performance after neoadjuvant chemotherapy in locally advanced breast cancer: A systematic review and meta-analysis. Int J Cancer. 2016;138(2):472-480.10.1002/ijc.2964426084763
- 7. Zengel B, Yararbas U, Sirinocak A, et al. Sentinel lymph node biopsy in breast cancer: review on various methodological approaches. Tumori. 2013;99(2):149-5310.1177/030089161309900205
- 8. Asoglu O, Ozmen V, Karanlik H, et al. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy. Acta Chir Belg. 2005;105(3):291-296.10.1080/00015458.2005.1167971916018523
- 9. Thill M, Kurylcio A2, Welter R. The Central-European SentiMag study: Sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope. Breast. 2014;23(2):175-179.10.1016/j.breast.2014.01.00424484967
- 10. Bakhtiar N, Jaleel F, Moosa FA, Qureshi NA, Jawaid M. Sentinel lymph node identification by blue dye in patients with breast carcinoma. Pak J Med Sci. 2016;32(2):448-451.
- 11. O'Reilly EA, Prichard RS, Al Azawi D, et al. The Value of Isosulfan Blue Dye in Addition to Isotope Scanning in the Identification of the Sentinel Lymph Node in Breast Cancer Patients With a Positive Lymphoscintigraphy: A Randomized Controlled Trial (ISRCTN98849733). Ann Surg. 2015;262(2):243-248.10.1097/SLA.000000000000121325822674
- 12. Kern KA. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. J Am Coll Surg. 2002;195(4):467-475.10.1016/S1072-7515(02)01312-1
- 13. Garbay JR, Skalli-Chrisostome D, Leymarie N, Sarfati B, Rimareix F, Mazouni C. The Role of Blue Dye in Sentinel Node Detection for Breast Cancer: A Retrospective Study of 203 Patients. Breast Care (Basel). 2016;11(2):128-132.10.1159/000445368488124727239175
- 14. V Klimberg, C Townsend. Atlas of Breast Surgical Techniques. 1st Edition. Ed. SaundersPrint Book. ISBN :9781416046912, 2009.